<DOC>
	<DOC>NCT02839278</DOC>
	<brief_summary>The aim of the study is to investigate in vitro the impact of a novel anti-inflammatory treatment on costimulatory molecules expressed on monocytes.</brief_summary>
	<brief_title>Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Immunemediated inflammatory disease (nonST segment elevation myocardial infarction, Rheumatoid arthritis, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Crohn's disease, Ulcerative colitis, Cystic fibrosis, Psoriasis or major depressive episode) Patient able to understand the reason of the study Patient not opposed to the conservation of biological samples for scientific research Pregnant woman Subject without health insurance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Immunomodulation</keyword>
</DOC>